Duke; Richard C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Duke; Richard C..The latest application filed is for "use of tumor fas expression to determine response to anti-cancer therapy".

Company Profile

0.22.18

Duke; Richard C. - Denver CO
Duke; Richard C - Denver CO

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of tumor Fas expression to determine response to anti-cancer therapy Grant 10,352,936 - Modiano , et al. July 16, 2	2019-07-16
Methods of treating symptoms associated with menopause and hormonal variations with G-CSF Grant 9,216,206 - Duke , et al. December 22, 2	2015-12-22
Use Of Tumor Fas Expression To Determine Response To Anti-cancer Therapy App 20140294754 - Modiano; Jaime ; et al.	2014-10-02
Yeast-based therapeutic for chronic hepatitis C infection Grant 8,821,892 - Duke , et al. September 2, 2	2014-09-02
Immunotherapy for chronic hepatitis C virus infection Grant 8,728,489 - Apelian , et al. May 20, 2	2014-05-20
Viral vectors encoding apoptosis-inducing proteins and methods for making and using the same Grant 8,715,645 - Bellgrau , et al. May 6, 2	2014-05-06
Yeast-based therapeutic for chronic hepatitis C infection Grant 8,388,980 - Duke , et al. March 5, 2	2013-03-05
Yeast-hiv Antigen Compositions And Methods Of Using The Same App 20130052220 - Duke; Richard C. ; et al.	2013-02-28
N-Terminal Dimerization Methods with Bis-Amindino Acid and Bis-Thioimidate Derivatives App 20120220753 - Gera; Lajos ; et al.	2012-08-30
Yeast-antigen compositions and methods of using the same Grant 8,221,763 - Duke , et al. July 17, 2	2012-07-17
Compositions And Methods For Treating Symptoms Associated With Menopause, Hormonal Variations And Arthritis App 20120014910 - Duke; Debra M. ; et al.	2012-01-19
Immunotherapy For Chronic Hepatitis C Virus Infection App 20110256098 - Apelian; David ; et al.	2011-10-20
Yeast-based therapeutic for chronic hepatitis C infection Grant 8,007,816 - Duke , et al. August 30, 2	2011-08-30
Yeast-Based Vaccine for Inducing an Immune Response App 20100196411 - Duke; Richard C. ; et al.	2010-08-05
Yeast-Based Therapeutic for Chronic Hepatitis C Infection App 20100150963 - Duke; Richard C. ; et al.	2010-06-17
Yeast-based vaccine for inducing an immune response Grant 7,736,642 - Duke , et al. June 15, 2	2010-06-15
Yeast-based therapeutic for chronic hepatitis C infection Grant 7,632,511 - Duke , et al. December 15, 2	2009-12-15
Yeast-Dendritic Cell Vaccines and Uses Thereof App 20090304741 - DUKE; RICHARD C. ; et al.	2009-12-10
Yeast-based therapeutic for chronic hepatitis C infection Grant 7,625,569 - Duke , et al. December 1, 2	2009-12-01
Yeast-antigen compositions methods of making the same Grant 7,595,060 - Duke , et al. September 29, 2	2009-09-29
Yeast-based Therapeutic for Chronic Hepatitis C Infection App 20090074805 - Duke; Richard C. ; et al.	2009-03-19
Yeast-based therapeutic for chronic hepatitis C infection Grant 7,439,042 - Duke , et al. October 21, 2	2008-10-21
Yeast-based Therapeutic For Chronic Hepatitis C Infection App 20080107671 - Duke; Richard C. ; et al.	2008-05-08
Yeast-based Therapeutic For Chronic Hepatitis C Infection App 20080069831 - Duke; Richard C. ; et al.	2008-03-20
Yeast-based Vaccine for Inducing an Immune Response App 20080003239 - Duke; Richard C. ; et al.	2008-01-03
Yeast-dendritic cell vaccines and uses thereof App 20070166323 - Duke; Richard C. ; et al.	2007-07-19
Yeast-dendritic cell vaccines and uses thereof Grant 7,083,787 - Duke , et al. August 1, 2	2006-08-01
Yeast-based therapeutic for chronic hepatitis C infection App 20060110755 - Duke; Richard C. ; et al.	2006-05-25
Yeast-dendritic Cell Vaccines And Uses Thereof App 20060104986 - Duke; Richard C. ; et al.	2006-05-18
Viral vectors encoding apoptosis-inducing proteins and methods for making and using the same App 20040224389 - Bellgrau, Donald ; et al.	2004-11-11
Use of Fas ligand to suppress T-lymphocyte-mediated immune responses Grant 6,325,999 - Bellgrau , et al. December 4, 2	2001-12-04
Yeast-based delivery vehicles Grant 5,830,463 - Duke , et al. November 3, 1	1998-11-03
Use of fas ligand to supress T-lymphocyte-mediated immune responses Grant 5,759,536 - Bellgrau , et al. June 2, 1	1998-06-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.